On Thursday 07/18/2024 the closing price of the Universal Health Services Inc. share was $181.42 on BTT.
Compared to the opening price on Thursday 07/18/2024 on BTT of $182.10, this is a drop of 0.37%.
Universal Health Services Inc.'s market capitalization is $12.11 B by 59.68 M shares outstanding.
Is Universal Health Services stock a Buy, Sell or Hold?
Universal Health Services stock has received a consensus rating of hold. The average rating score is and is based on 21 buy ratings, 28 hold ratings, and 9 sell ratings.What was the 52-week low for Universal Health Services stock?
The low in the last 52 weeks of Universal Health Services stock was 119.96. According to the current price, Universal Health Services is 150.73% away from the 52-week low.What was the 52-week high for Universal Health Services stock?
The high in the last 52 weeks of Universal Health Services stock was 193.56. According to the current price, Universal Health Services is 93.42% away from the 52-week high.What are analysts forecasts for Universal Health Services stock?
The 58 analysts offering price forecasts for Universal Health Services have a median target of 161.05, with a high estimate of 236.00 and a low estimate of 111.00. The median estimate represents a 112.27 difference from the last price of 180.82.Universal Health Services Stock Snapshot
173.84
Bid
1.00
Bid Size
184.98
Ask
4.00
Ask Size
7/19/2024
Date
3:59 PM
Time
0.00
Volume
181.42
Prev. Close
0.00
Open
59.68 M
Number of Shares
119.96
52 Week Low
193.56
52 Week High
180.82
0.80
Dividend in USD
0.52
Dividend Yield
14.90
P/E Ratio
95.17
Free Float in %
10.35
EPS in USD
91.53
Book Value per Share in USD
18.08
Cash Flow per Share in USD
Universal Health Services News More News
Historical Prices for Universal Health Services
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Universal Health Services Analyst Data
Total Analysts: 59
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 103.00
Median: 160.07
Highest: 236.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Universal Health Services Analyst Opinions
- All
- Buy
- Hold
- Sell
Date | Analyst | Rating | Price | |||
---|---|---|---|---|---|---|
07/10/24 | Barclays Capital | Maintained Hold | $198 | |||
07/09/24 | Cantor Fitzgerald | Maintained Sell | $162 | |||
07/02/24 | Cantor Fitzgerald | Maintained Sell | $162 | |||
06/26/24 | Baird Patrick & Co | Upgraded to Buy | $236 | |||
05/30/24 | J.P. Morgan | Maintained Hold | $186 | |||
05/30/24 | Baird Patrick & Co | Maintained Hold | $198 | |||
05/20/24 | UBS | Upgraded to Buy | $226 | |||
05/07/24 | RBC Capital Markets | Maintained Hold | $189 | |||
04/26/24 | Barclays Capital | Maintained Hold | $189 | |||
04/25/24 | Stephens Inc. | Maintained Hold | $185 | |||
04/12/24 | Deutsche Bank | Maintained Buy | $203 | |||
04/10/24 | Cantor Fitzgerald | Maintained Sell | $156 | |||
03/28/24 | Wells Fargo & Co | Maintained Buy | $200 | |||
03/13/24 | J.P. Morgan | Maintained Hold | $182 | |||
03/12/24 | RBC Capital Markets | Maintained Hold | $183 | |||
03/06/24 | Mizuho | Maintained Buy | $200 | |||
03/06/24 | Barclays Capital | Maintained Hold | $181 | |||
03/05/24 | Cantor Fitzgerald | Maintained Sell | $156 | |||
03/04/24 | Goldman Sachs | Maintained Buy | $189 | |||
02/29/24 | Cantor Fitzgerald | Maintained Sell | $156 | |||
02/29/24 | Citigroup Corp. | Maintained Buy | $193 | |||
02/29/24 | UBS | Maintained Hold | $177 | |||
01/02/24 | Wells Fargo & Co | Upgraded to Buy | $177 | |||
12/11/23 | Goldman Sachs | Upgraded to Buy | ||||
11/17/23 | J.P. Morgan | Maintained Hold | $144 | |||
10/20/23 | Wells Fargo & Co | Maintained Hold | $139 | |||
09/21/23 | Barclays Capital | Maintained Hold | $142 | |||
09/14/23 | Cantor Fitzgerald | Maintained Sell | $148 | |||
07/27/23 | Credit Suisse | Maintained Buy | $169 | |||
07/26/23 | Stephens Inc. | Maintained Hold | $155 | |||
07/11/23 | Mizuho | Maintained Buy | $170 | |||
06/02/23 | Bank of America Merrill Lynch | Maintained Buy | $163 | |||
05/16/23 | Goldman Sachs | Maintained Sell | $139 | |||
05/16/23 | Mizuho | Maintained Buy | $150 | |||
04/27/23 | Citigroup Corp. | Maintained Buy | $165 | |||
04/27/23 | Stephens Inc. | Maintained Hold | $145 | |||
04/27/23 | Deutsche Bank | Maintained Buy | $155 | |||
04/27/23 | RBC Capital Markets | Maintained Hold | $152 | |||
04/27/23 | Credit Suisse | Maintained Buy | $163 | |||
04/25/23 | Barclays Capital | Upgraded to Hold | $142 | |||
04/21/23 | Cantor Fitzgerald | Maintained Sell | $143 | |||
04/19/23 | J.P. Morgan | Maintained Hold | $133 | |||
03/06/23 | Deutsche Bank | Maintained Buy | $145 | |||
03/06/23 | Mizuho | Maintained Buy | $140 | |||
03/06/23 | Wells Fargo & Co | Maintained Hold | $138 | |||
03/03/23 | Credit Suisse | Maintained Buy | $153 | |||
03/01/23 | Wolfe Research | Downgraded to Hold | ||||
03/01/23 | RBC Capital Markets | Maintained Hold | $130 | |||
02/28/23 | Stephens Inc. | Maintained Hold | $155 | |||
01/24/23 | UBS | Upgraded to Hold | $167 |
Universal Health Services Estimates* in USD
2024 | 2025 | 2026 | 2027 | |
---|---|---|---|---|
Revenue | 15,591 | 16,476 | 17,429 | 17,409 |
Dividend | 0.70 | 0.71 | 0.69 | - |
Dividend Yield (in %) | 0.39 % | 0.39 % | 0.38 % | - |
EPS | 13.83 | 15.22 | 17.20 | 18.44 |
P/E Ratio | 13.07 | 11.88 | 10.51 | 9.81 |
EBIT | 1,418 | 1,504 | 1,634 | 1,639 |
EBITDA | 2,018 | 2,142 | 2,283 | 2,320 |
Net Profit | 933 | 990 | 1,082 | 1,122 |
Net Profit Adjusted | 930 | 989 | 1,077 | 1,122 |
Pre-Tax Profit | 1,215 | 1,299 | 1,424 | 1,457 |
Net Profit (Adjusted) | 1,249 | 1,343 | 1,459 | - |
EPS (Non-GAAP) ex. SOE | 13.83 | 15.22 | 17.20 | 18.44 |
EPS (GAAP) | 13.95 | 15.42 | 17.44 | 18.44 |
Gross Income | 7,990 | 8,420 | 8,880 | - |
Cash Flow from Investing | -1,095 | -663 | -683 | -643 |
Cash Flow from Operations | 1,805 | 1,698 | 1,801 | 2,008 |
Cash Flow from Financing | -1,095 | -663 | -683 | -643 |
Cash Flow per Share | 24.52 | 25.97 | 29.21 | - |
Free Cash Flow | 970 | 827 | 950 | 994 |
Free Cash Flow per Share | 17.26 | 13.21 | 14.93 | 16.35 |
Book Value per Share | 98.10 | 109.51 | 123.34 | - |
Net Debt | 4,517 | 4,380 | 4,183 | 3,640 |
Research & Development Exp. | - | - | - | - |
Capital Expenditure | 891 | 924 | 953 | 1,006 |
Selling, General & Admin. Exp. | - | - | - | - |
Shareholder’s Equity | 6,483 | 6,817 | 7,220 | 8,087 |
Total Assets | 14,197 | 14,783 | 15,424 | 16,474 |
Previous Quarter ending 06/30/24 |
Current Quarter ending 09/30/24 |
Next Quarter ending 12/31/24 |
Current Year ending 12/31/24 |
Next Year ending 12/31/25 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | 16 | 16 | 16 | 16 | 17 |
Average Estimate | 3.303 USD | 3.086 USD | 3.713 USD | 13.830 USD | 15.220 USD |
Year Ago | 2.444 USD | 2.424 USD | 3.190 USD | 10.350 USD | - |
Publish Date | 7/24/2024 | 10/23/2024 | 2/26/2025 | - | - |
Revenue Estimates | |||||
No. of Analysts | 15 | 15 | 15 | 15 | 15 |
Average Estimate | 3,865 USD | 3,878 USD | 4,004 USD | 15,591 USD | 16,476 USD |
Year Ago | 3,548 USD | 3,563 USD | 3,704 USD | 14,282 USD | - |
Publish Date | 7/24/2024 | 10/23/2024 | 2/26/2025 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales | 14,281.98 | 13,399.37 | 12,642.12 | 11,558.90 | 11,378.26 | 10,772.28 | 10,407.27 |
Change of sales in % | 6.59 | 5.99 | 9.37 | 1.59 | 5.63 | 3.51 | 6.57 |
Gross profit on sales | 1,175.38 | 1,061.11 | 1,377.49 | 1,356.99 | 1,313.54 | 1,227.30 | 1,277.58 |
Gross profit on sales change in % | 10.77 | -22.97 | 1.51 | 3.31 | 7.03 | -3.94 | 0.20 |
Operating income | 1,175.38 | 1,061.11 | 1,377.49 | 1,356.99 | 1,313.54 | 1,227.30 | 1,277.58 |
Operating income change in % | 10.77 | -22.97 | 1.51 | 3.31 | 7.03 | -3.94 | 0.20 |
Income before tax | 940.43 | 866.26 | 1,293.31 | 1,252.08 | 1,066.34 | 1,034.53 | 1,135.01 |
Income before tax change in % | 8.56 | -33.02 | 3.29 | 17.42 | 3.08 | -8.85 | -1.85 |
Income after tax | 717.49 | 674.86 | 989.53 | 940.97 | 812.83 | 778.61 | 751.94 |
Income after tax change in % | 6.32 | -31.80 | 5.16 | 15.77 | 4.39 | 3.55 | 7.10 |
Balance Sheet in Mio. USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Total liabilities | 8,154.94 | 7,918.48 | 6,895.37 | 7,070.34 | 6,085.05 | 5,795.40 | 5,703.69 |
Long-term liabilities per share | 91.42 | 85.01 | 63.71 | 53.95 | 52.15 | 47.58 | - |
Equity | 6,201.91 | 5,970.05 | 6,198.17 | 6,406.54 | 5,583.20 | 5,470.09 | 5,058.14 |
Equity change in % | 3.86 | -2.78 | -3.60 | 14.77 | 2.13 | 8.01 | 10.07 |
Balance sheet total | 14,356.85 | 13,888.52 | 13,093.54 | 13,476.88 | 11,668.25 | 11,265.48 | 10,761.83 |
Balance sheet total change in % | 3.37 | 6.07 | -2.84 | 15.50 | 3.58 | 4.68 | 4.30 |
Key Data in USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales per share | 203.66 | 181.48 | 151.06 | 135.05 | 127.79 | 114.90 | 108.04 |
P/E ratio (year end quote, basic EPS) | 14.90 | 15.41 | 10.97 | 12.47 | 15.72 | 14.03 | 14.52 |
P/E ratio (year end quote, diluted EPS) | 14.90 | 15.41 | 10.97 | 12.47 | 15.72 | 14.03 | 14.52 |
P/E ratio (year end quote) | 14.90 | 15.41 | 10.97 | 12.47 | 15.72 | 14.03 | 14.52 |
Dividend yield in % | 0.52 | 0.57 | 0.62 | 0.15 | 0.42 | 0.34 | 0.35 |
Equity ratio in % | 42.83 | 42.63 | 46.51 | 46.87 | 47.17 | 47.84 | 46.36 |
Debt ratio in % | 56.80 | 57.01 | 52.66 | 52.46 | 52.15 | 51.44 | 53.00 |
Universal Health Services Insider Activity
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
MILLER ALAN B | 05/21/2024 | 4,064.00 | n/a | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 9,162.00 | 4,064.00 | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 4,064.00 | n/a | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 9,162.00 | 4,064.00 | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 5,421.00 | n/a | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 12,214.00 | 5,421.00 | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 19,702.00 | 1,128,174.00 | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 19,702.00 | 1,147,876.00 | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 26,265.00 | 1,167,578.00 | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 10,540.00 | 17,672.00 | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 10,540.00 | 17,672.00 | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 14,051.00 | 23,565.00 | n/a | Sell | No |
MILLER ALAN B | 05/21/2024 | 9,162.00 | 1,158,712.00 | n/a | Buy | No |
MILLER ALAN B | 05/21/2024 | 9,162.00 | 1,149,550.00 | n/a | Buy | No |
MILLER ALAN B | 05/21/2024 | 12,214.00 | 1,140,388.00 | n/a | Buy | No |
MILLER ALAN B | 05/21/2024 | 19,702.00 | 19,702.00 | n/a | Buy | No |
MILLER ALAN B | 05/21/2024 | 19,702.00 | 19,702.00 | n/a | Buy | No |
MILLER ALAN B | 05/21/2024 | 26,265.00 | 26,265.00 | n/a | Buy | No |
MILLER ALAN B | 05/21/2024 | 10,540.00 | 1,193,843.00 | n/a | Buy | No |
MILLER ALAN B | 05/21/2024 | 10,540.00 | 1,183,303.00 | n/a | Buy | No |
MILLER ALAN B | 05/21/2024 | 14,051.00 | 1,172,763.00 | n/a | Buy | No |
Nimetz Warren J. | 05/15/2024 | 725.00 | 3,971.00 | 180.32 | Sell | No |
Singer Maria Ruderman | 05/14/2024 | 1,097.00 | 4,265.00 | n/a | Buy | No |
Nimetz Warren J. | 05/14/2024 | 1,097.00 | 4,696.00 | n/a | Buy | No |
SUSSMAN ELLIOT J MD MBA | 05/14/2024 | 1,097.00 | 5,048.00 | n/a | Buy | No |
Universal Health Services Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2023 | Universal Health Services Inc. | 0.80 | 0.52 | USD |
2022 | Universal Health Services Inc. | 0.80 | 0.57 | USD |
2021 | Universal Health Services Inc. | 0.80 | 0.62 | USD |
2020 | Universal Health Services Inc. | 0.20 | 0.15 | USD |
2019 | Universal Health Services Inc. | 0.60 | 0.42 | USD |
2018 | Universal Health Services Inc. | 0.40 | 0.34 | USD |
2017 | Universal Health Services Inc. | 0.40 | 0.35 | USD |
2016 | Universal Health Services Inc. | 0.40 | 0.38 | USD |
2015 | Universal Health Services Inc. | 0.40 | 0.33 | USD |
2014 | Universal Health Services Inc. | 0.30 | 0.27 | USD |
2013 | Universal Health Services Inc. | 0.20 | 0.25 | USD |
2012 | Universal Health Services Inc. | 0.20 | 0.41 | USD |
2011 | Universal Health Services Inc. | 0.20 | 0.51 | USD |
2010 | Universal Health Services Inc. | 0.20 | 0.46 | USD |
2009 | Universal Health Services Inc. | 0.15 | 0.48 | USD |
*Yield of the Respective Date
Universal Health Services Inc. Calendar
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 3.303 USD | Q2 2024 Earnings Release | 07/24/2024 |
Earnings Report | 3.086 USD | Q3 2024 Earnings Release | 10/23/2024 |
Earnings Report | 3.713 USD | Q4 2024 Earnings Release | 02/26/2025 |
Earnings Report | 4.036 USD | Q1 2025 Earnings Release | 04/28/2025 |
Universal Health Services Inc. Past Events
Event | Actual EPS | Info | Date |
---|---|---|---|
Annual General Meeting | - | Annual General Meeting | 05/15/2024 |
Universal Health Services Profile
Universal Health Services, Inc. engages in providing hospital and healthcare services. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services, and Other. The Acute Care Hospital Services segment includes hospitals, freestanding emergency departments, and ambulatory centers. The Behavioral Health Care Services segment offers treatment programs for depression, anxiety, psychotic diagnoses, bipolar disorder, post-traumatic stress disorder, and neurorehabilitation. The Other segment consists of centralized services such as information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising, and design and construction. The company was founded by Alan B. Miller in 1979 and is headquartered in King of Prussia, PA.
Moody’s Daily Credit Risk Score
Universal Health Services Shareholder
Owner | in % |
---|---|
Freefloat | 95.17 |
The Vanguard Group, Inc. | 11.80 |
Vanguard Group, Inc. (Subfiler) | 11.45 |
First Eagle Investment Management LLC | 7.77 |
First Eagle Investment Management LLC | 7.76 |
First Eagle Global Fund | 5.64 |
State Street Corp. | 4.56 |
Fidelity Management & Research Co. LLC | 4.48 |
Glenview Capital Management LLC | 3.44 |
Invesco Advisers, Inc. | 3.33 |
Massachusetts Financial Services Co. | 3.14 |
Vanguard Total Stock Market ETF | 3.01 |
Alan B. Miller, MBA | 2.94 |
BlackRock Fund Advisors | 2.91 |
Vanguard Health Care Fund | 2.72 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
Universal Health Services Management
Name | Job |
---|---|
Steve G. Filton | Chief Financial Officer, Secretary & Executive VP |
Ehab Hanna | Chief Medical Information Officer & Vice President |
Warren J. Nimetz | Director |
Genevieve P. Owsiany | Director-Corporate Accounting |
Matthew J. Peterson | EVP & President-Behavioral Health Division |
Alan B. Miller | Executive Chairman |
Edward H. Sim | Executive VP & President-Acute Care Division |
Elliot J. Sussman | Independent Director |
Maria Ruderman Singer | Independent Director |
Nina Chen-Langenmayr | Independent Director |
Eileen Claire McDonnell | Lead Independent Director |
Jane Crawford | Media Contact |
Marc Daniel Miller | President, Chief Executive Officer & Director |
Maria Zangardi | Senior VP-Human Resources & Corporate Officer |
Charles F. Boyle | Senior Vice President & Controller |
Matthew D. Klein | Senior Vice President & General Counsel |
Michael S. Nelson | Senior Vice President-Strategic Services |
Cheryl K. Ramagano | Treasurer & Senior Vice President |